In Hashimoto's thyroiditis, thyrocytes die by apoptosis. Whether this is th
e result of impaired antiapoptotic gene expression or hyperexpression of pr
oapoptotic signals or other mechanisms is not fully established. Following
the suggestion that thyrocytes from Hashimoto's glands die by a fratricidal
killing mediated by Fas/Fas ligand, we have investigated whether thyroid c
ells from different clinical conditions are able to kill Fas-expressing tar
get cells. We have studied whether this effector ability was mediated by Fa
s/Fas ligand, perforin or other death receptors/ligands, i.e., tumor necros
is factor-related apoptosis-inducing ligand (TRAIL)/tumor necrosis factor-r
elated apoptosis-inducing ligand receptor (TRAIL-R). We have confirmed that
thyroid preparations can kill Fas-expressing HUT78 targets through apoptos
is. Cell death was only partially dependent on Fas/Fas ligand but it was tr
ypsin-sensitive. Blocking perforin did not affect Fas-expressing target kil
ling while caspase inhibitors had a consistent although limited effect. Thy
roid cells were not sensitive to TRAIL/TRAIL-R. We have also found that bot
h thyrocytes and lymphocytes from Graves' disease thyroids were effective a
t killing autologous and heterologous Fas-expressing targets. Conversely, k
illing of these targets could be shown only with lymphocytes (but not with
thyrocytes) from Hashimoto's glands. In Hashimoto's thyroiditis, thyrocytes
were poorly functional while lymphocytes were able to operate as effectors
. It is envisaged that thyrocyte death in Hashimoto's would result from aut
ologous thyrocyte killing perpetrated by lymphocytes. Death receptors/ligan
ds would appear to play a role. However, a caspase-independent mechanism ma
y also coexist and contribute to cell death in Hashimoto's thyroiditis.